Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/INHIBIKASE-THERAPEUTICS-I-114338452/news/Inhibikase-Therapeutics-gibt-Veroffentlichung-der-Ergebnisse-seiner-Phase-1-Studien-mit-Risvodetini-45835456/?utm_source=whatsapp&utm_medium=social&utm_campaign=share